Literature DB >> 1111835

Memory enhancement by central administration of norepinephrine.

L Stein, J D Belluzzi, C D Wise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1111835     DOI： 10.1016/0006-8993(75)90989-0

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  15 in total

1.  A study of the effects of cranial electrical stimulation on attention and concentration.

Authors:  S Southworth
Journal:  Integr Physiol Behav Sci       Date:  1999 Jan-Mar

2.  Proceedings Correlation between ultrastructure and histochemistry of mammalian intrafusal muscle fibres.

Authors:  R W Banks; D Barker; D W Harker; M J Stacey
Journal:  J Physiol       Date:  1975-11       Impact factor: 5.182

3.  DDC-induced amnesia and norepinephrine: a correlated behavioral-biochemical analysis.

Authors:  M V Solanto; M D Hamburg
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

Review 4.  Neurotransmitter replacement therapy in Alzheimer's disease.

Authors:  E Mohr; T Mendis; I N Rusk; J D Grimes
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

5.  Norepinephrine induces pathway-specific long-lasting potentiation and depression in the hippocampal dentate gyrus.

Authors:  D Dahl; J M Sarvey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice.

Authors:  J J Kim; J C Shih; K Chen; L Chen; S Bao; S Maren; S G Anagnostaras; M S Fanselow; E De Maeyer; I Seif; R F Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

7.  Development of amygdaloid cholinergic mediation of passive avoidance learning in the rat. I. Muscarinic mechanisms.

Authors:  V Duméry; D Blozovski
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

8.  Differences in the effects of post-trial chlorpromazine, reserpine, and amphetamine on discrimination learning in rats.

Authors:  K Ishikawa; S Saito
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

9.  Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Authors:  J J Mann; M Stanley; R D Kaplan; J Sweeney; A Neophytides
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

10.  The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.

Authors:  J T Coull; B J Sahakian; J R Hodges
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.